CoChat
Sign Up
Cited by 119

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway

Palumbo, T, Faucz, F R, Azevedo, M, Xekouki, P, Iliopoulos, D, Stratakis, C A·2013·Oncogene
DOI 10.1038/onc.2012.190PMC PMC4034118
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2012.190

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 48

  1. Bartel DP . MicroRNAs: Genomics,biogenesis,mechanism and function. Cell 2004; 116: 281–297. · DOI
  2. Croce CM, GA Calin . MicroRNAs cancer and stem cell division. Cell 2005; 122: 6–7. · DOI
  3. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753–3756. · DOI
  4. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065–7070. · DOI · Paper page
  5. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X et al. MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009; 15: 2281–2290. · DOI
  6. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A . High expression of precursor microRNA-155-/BIC RNA in children with Burkitt lymphoma. Genes Chromosome Cancer 2004; 39: 167–169. · DOI
  7. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. The role of microRNA gene in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2005; 102: 19075–19080. · DOI
  8. Stilling G, Sun Z, Zhang S, Jin L, Righi A, Kovacs G et al. MicroRNAs expression in ACTH-producing pituitary tumors up regulation of microRNA-122 and -493 in pituitary carcinoma. Endocrine 2010; 38: 67–75. · DOI
  9. Rahbari R, Holloway AK, He M, Khanafshar E, Clark OH, Kebebew E . Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol 2011; 2: 1158–1165. · DOI
  10. Asa SL, Ezzat S . The cytogenesis and pathogenesis of pituitary adenoma. Endocr Rev 1998; 19: 798–827.
  11. Asa SL, Ezzat S . The pathogenesis of pituitary tumors. Nat Rev Cancer 2001; 2: 836–849. · DOI
  12. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC . MiR-15a and miR-16-1 downregulation in pituitary adenomas. J Cell Physiol 2005; 204: 280–285. · DOI
  13. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 2007; 210: 370–377. · DOI
  14. Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, Silva WA et al. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 2009; 94: 320–323. · DOI
  15. Pack S, Kirshner LS, Pak E, Carney JA, Zhuang Z, Stratakis CA . Pituitary tumors in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex): evidence for progression from somatomammotroph hyperplasia to adenoma. J Clin Encocrinol Metab 2000; 85: 3860–3865.
  16. Pack SD, Qin LX, Pak E, Wang Y, Ault DO, Mannan P et al. Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization. Genes, Chromosomes Cancer 2005; 43: 72–82. · DOI
  17. Galland F, Kamenicky P, Affres H, Reznik Y, Pontvert D, Le Bouc Y et al. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab 2006; 91: 4957–4961. · DOI
  18. Boikos SA, Stratakis CA . Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary 2006; 9: 203–209. · DOI
  19. Bossis I, Voutetakis A, Matyakhina L, Pack S, Abu-Asab M, Bourdeau I et al. A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus. J Med Genet 2004; 41: 596–600. · DOI
  20. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009; 119: 3626–3636. · DOI
  21. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944–13949. · DOI
  22. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. Ras is regulated by the let-7 microRNA family. Cell 2005; 120: 635–647. · DOI
  23. Mayr C, Hemann MT, Bartel DP . Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576–1579. · DOI
  24. Iliopoulos D, Hirsch HA, Struhl K . An epigenetic switch involving NF-kappaB, Lin-28, Let-7 MicroRNA, and IL-6 links inflammation to cell transformation. Cell 2009; 139: 693–706. · DOI · Paper page
  25. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43–50. · DOI
  26. Kashuba VI, Li J, Wang F, Senchenko VN, Protopopov A, Malyukova A et al. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A 2004; 101: 4906–4911. · DOI
  27. Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C et al. MiR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res 2010; 70: 3638–3646. · DOI
  28. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008; 68: 9125–9130. · DOI · Paper page
  29. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23: 1327–1337. · DOI · Paper page
  30. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP . Pten and p27KIP21cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 2001; 27: 222–224. · DOI
  31. Podsypanina K, Ellenson LH . Mutation of PTEN/Mmac1 in mice causes neoplasia inmultiple organ systems. Proc Natl Acad Sci USA 1999; 96: 1563–1568. · DOI
  32. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A et al. Pten dose dictates cancer progression in the prostate. Plos Biol 2003; 1: 1E59. · DOI
  33. Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK et al. Mitogen activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression throught an NF-kappa B-dependent pathway. J Biol Chem 2007; 282: 3507–3519. · DOI
  34. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ . Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425: 962–967. · DOI
  35. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M . Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999; 13: 2678–2690. · DOI
  36. van Lohuizen M, Frasch M, Wientjens E, Berns A . Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2. Nature 1991; 353: 353–355. · DOI
  37. Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF et al. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 2011; 10: 10. · DOI
  38. Lukacs RU, Memarzadeh S, Wu H, Witte ON . Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 2010; 7: 682–693. · DOI
  39. Liu WL, Guo XZ, Zhang LJ . Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer 2010; 10: 467. · DOI
  40. Sinha AU, Kaimal V, Chen J, Jegga AG . Dissecting microregulation of a master regulatory network. BMC Genomics 2008; 9: 88. · DOI
  41. Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010; 78: 457–463. · DOI
  42. Farrell WE, Azevedo MF, Batista DL, Smith A, Bourdeau I, Horvath A et al. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma. J Clin Endocrinol Metab 2011; 96: E1905–E1914. · DOI
  43. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the carney complex. Nat Genet 2000; 26: 89–92. · DOI · Paper page
  44. Kovacs K, Horvath E, Thomer MO, Rogol AD . Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virch Arch Pathol Anat 1984; 403: 77–86. · DOI
  45. Horvath A, Bertherat J, Groussin L, Guillaud-Bataille M, Tsang K, Cazabat L et al. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat 2010; 31: 369–379. · DOI
  46. Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S et al. A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report. J Med Case Reports (BMC) 2007; 1: 1–6. · DOI
  47. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA et al. An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis. Cell 2011; 147: 1233–1247. · DOI
  48. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K . STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39: 493–506. · DOI · Paper page

Cited by

Sorted by citations

See all 119

Metadata

Authors
Palumbo, T., Faucz, F. R., Azevedo, M., Xekouki, P., Iliopoulos, D., & Stratakis, C. A.
Venue
Oncogene
Publisher
Springer Science and Business Media LLC
Published
2012-05-21
Volume
32
Issue
13
Pages
1651-1659
ISSN
  • 0950-9232
  • 1476-5594
DOI
10.1038/onc.2012.190
PMC
PMC4034118
Cited by
119
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway. https://app.cochat.ai/papers/10.1038/onc.2012.190
The paper
Palumbo, T., Faucz, F. R., Azevedo, M., Xekouki, P., Iliopoulos, D., & Stratakis, C. A. (2013). Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway. Oncogene. https://doi.org/10.1038/onc.2012.190